West Chester, PA, United States of America

Elaine Merisko-Liversidge

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Elan Pharma International Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elaine Merisko-Liversidge. Retrieved from https://idiyas.com/inventor/elaine-merisko-liversidge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elaine Merisko-Liversidge: Innovator in Nanoparticulate Compositions

Introduction

Elaine Merisko-Liversidge is a prominent inventor based in West Chester, PA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of nanoparticulate compositions.

Latest Patents

Elaine holds a patent for "Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors." This invention describes nanoparticulate compositions that comprise at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer. The compositions have an average particle size of less than about 2000 nm. Additionally, the patent outlines methods for making and using these compositions.

Career Highlights

Elaine is associated with Elan Pharma International Limited, where she applies her expertise in pharmaceutical innovations. Her work focuses on enhancing drug delivery systems through advanced nanoparticle technology.

Collaborations

Elaine has collaborated with notable professionals in her field, including H William Bosch and Greta G Cary. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Elaine Merisko-Liversidge is a trailblazer in the realm of nanoparticulate compositions, with her patent reflecting her commitment to advancing pharmaceutical technology. Her work continues to influence the industry and improve therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…